MedicalMex is launching a new informational and support service for internationally trained physicians interested in working in Texas under the new Texas House Bill 2038 (HB2038). This program is especially focused on serving doctors licensed in Mexico, though it is open to candidates from any country who meet the general eligibility criteria.

Texas HB2038, also referred to as the DOCTOR Act, was signed into law in June 2025 and takes effect on September 1, 2025. It creates a new pathway for foreign-trained physicians and recent medical graduates to receive provisional or limited licenses to practice medicine in Texas.

This law was introduced in response to significant physician shortages in Texas, especially in rural and medically underserved communities. It acknowledges the skills of doctors trained outside the United States and offers a structured legal framework for them to contribute to the Texas healthcare system.

HB2038 is expected to be a game-changing opportunity for qualified international physicians, particularly from neighboring Mexico, to bring their talents into clinical practice in Texas.

HB2038 is designed to serve:

MedicalMex primarily focuses on Mexican-trained physicians, given our deep regional expertise and infrastructure, but we also welcome qualified candidates from Latin America, Asia, Africa, Europe, and beyond.

Texas HB2038 goes into effect on September 1, 2025. However, as of today, the Texas Medical Board (TMB) is still drafting final rules and licensing procedures.

Applications for provisional licensure are not yet open. MedicalMex is currently gathering inquiries and building a candidate and employer database so we can act quickly once the rules are finalized.

By joining our inquiry list, you will be among the first to receive updates and have your file reviewed for eligibility, documentation, and potential job matches.

Based on the current language of HB2038, a foreign-trained physician applicant is expected to meet the following criteria:

If an applicant does not yet have U.S. work authorization, MedicalMex will assist in obtaining H-1B or TN visa sponsorship through its network of employers.

This program offers a realistic, legal, and structured path for internationally trained doctors to begin practicing medicine in Texas under supervision. Key benefits include:

The HB2038 program not only opens a clinical pathway for international physicians—it also provides access to a new income bracket that reflects the value of medical services in the U.S. healthcare market.

These are the average expected wages for similar roles in Texas today:

Physicians (General): The average annual salary for physicians in Texas is approximately $213,818, with a typical range between $138,862 and $254,304, depending on specialty, setting, and years of experience.

Primary Care / General Practice (Provisionally Licensed Roles): Entry-level or supervised roles—such as those available to unmatched U.S. graduates or internationally trained physicians holding a provisional license under HB2038—are likely to fall at the lower end of the physician pay scale. These positions typically offer between $120,000 and $180,000 per year, especially in primary care settings such as family medicine, internal medicine, and rural general practice.

Specialists: International physicians who are licensed to practice in their specialty (such as surgery, cardiology, gastroenterology, or OB/GYN) may command higher salaries in the range of $200,000 to $400,000+ per year. However, under HB2038, provisional status and supervised conditions may result in lower initial compensation compared to fully licensed peers, with room for growth upon obtaining full licensure.

We invite both foreign-trained physicians and healthcare employers in Texas to submit an inquiry. This is not a formal application—just an opportunity to be contacted as soon as we are able to proceed.

For Physicians, please include:

For Healthcare Facilities, please include:

All information will be kept private and used only to facilitate future outreach and matching under the HB2038 framework.